Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

Convalescent Plasma to Stem Coronavirus in COVID negative participants (CSSC-001)

Research Question:
Does blood plasma from people who are recovered from COVID-19 infection help prevent COVID-19 infection when given to others?

Basic Study Information

Purpose:
This study will determine if plasma collected from the blood of people who have recovered from COVID-19 infection will help others who are at risk for getting COVID-19. Participants should be people who are at high risk for COVID-19 infection. They will receive a one-time infusion of plasma from a person who has recovered from a COVID-19 infection. Plasma will not have COVID-19 but will have antibodies to the virus. The purpose of this study is to determine if these antibodies will help keep people who are at high risk for getting COVID from getting infected. To be eligible you must have had close contact with someone who is COVID-19 positive and have a high risk for illness such as >=65, reside in a nursing home or long-term care facility, have chronic lung disease, asthma, heart disease, obesite, uncontrolled diabetes, renal failure, liver disease or cancer. Or you must be a healthcare professional with high risk exposure such as have had prolonged close contact with patients with COVID-19 who were not wearing a facemask while HCP nose and mouth were exposed to material potentially infectious with the virus causing COVID-19.

Location: University of Rochester
Study Reference #: 4964

Lead Researcher (Principal Investigator)

Lead Researcher:  Martin Zand

Study Contact Information

Study Coordinator: Susanne Heininger
Phone: (585) 273-1926
Email: Susanne_Heininger@URMC.Rochester.edu

Additional Study Details

Number of Visits:  2 to 5
Parking:  Free
Transportation Coverage:  No
Reimbursement:  Yes

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search